Madrigal Pharmaceuticals, Inc. (MDGL)
499.40
-0.31
(-0.06%)
USD |
NASDAQ |
Oct 02, 16:00
499.58
+0.18
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals Price : 499.40 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 505.00 | 505.00 | 491.05 | 499.40 | 289234.0 |
| Oct 01, 2026 | 502.28 | 510.00 | 497.72 | 499.71 | 204563.0 |
| Sep 30, 2026 | 513.10 | 515.00 | 501.81 | 503.96 | 262462.0 |
| Sep 29, 2026 | 513.73 | 518.66 | 505.32 | 509.44 | 214358.0 |
| Sep 28, 2026 | 515.10 | 525.00 | 502.68 | 517.04 | 333656.0 |
| Sep 25, 2026 | 513.75 | 523.96 | 511.31 | 516.56 | 153395.0 |
| Sep 24, 2026 | 513.65 | 521.77 | 510.57 | 513.21 | 219344.0 |
| Sep 23, 2026 | 523.00 | 526.00 | 502.62 | 513.02 | 315951.0 |
| Sep 22, 2026 | 525.77 | 528.42 | 516.62 | 518.83 | 266075.0 |
| Sep 21, 2026 | 536.04 | 536.04 | 515.98 | 521.96 | 186149.0 |
| Sep 18, 2026 | 535.08 | 537.73 | 526.65 | 531.52 | 330618.0 |
| Sep 17, 2026 | 534.69 | 539.29 | 526.26 | 534.40 | 153313.0 |
| Sep 16, 2026 | 523.00 | 529.93 | 517.45 | 529.09 | 298475.0 |
| Sep 15, 2026 | 539.25 | 539.71 | 513.36 | 523.26 | 259412.0 |
| Sep 14, 2026 | 540.00 | 541.34 | 527.97 | 540.06 | 156536.0 |
| Sep 11, 2026 | 536.02 | 546.56 | 531.36 | 534.49 | 187643.0 |
| Sep 10, 2026 | 543.12 | 543.12 | 519.10 | 533.12 | 225767.0 |
| Sep 09, 2026 | 529.50 | 549.97 | 526.88 | 546.66 | 281255.0 |
| Sep 08, 2026 | 534.17 | 540.00 | 526.67 | 534.16 | 199463.0 |
| Sep 04, 2026 | 536.82 | 547.92 | 535.60 | 541.08 | 177171.0 |
| Sep 03, 2026 | 548.83 | 552.08 | 540.44 | 542.61 | 143455.0 |
| Sep 02, 2026 | 543.54 | 551.45 | 537.10 | 546.93 | 202818.0 |
| Sep 01, 2026 | 540.03 | 548.60 | 532.66 | 538.71 | 165755.0 |
| Aug 31, 2026 | 530.60 | 542.05 | 523.29 | 540.03 | 134578.0 |
| Aug 28, 2026 | 539.38 | 542.16 | 528.28 | 533.76 | 268664.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Exelixis, Inc. | 58.39 |
| Insmed, Inc. | 111.12 |
| United Therapeutics Corp. | 541.70 |
| Karyopharm Therapeutics, Inc. | 0.8022 |
Price Related Metrics
| PS Ratio | 10.06 |
| PEG Ratio | -136.06 |
| Price to Book Value | 22.02 |
| Earnings Yield | -2.58% |
| Market Cap | 11.53B |
| PEGY Ratio | -136.06 |